Early Events in the Molecular Pathogenesis of Lung Cancer
Authors:
Open Access
- 30 June 2016
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 9 (7) , 518-527
Abstract
The majority of cancer-related deaths in the United States and worldwide are attributed to lung cancer. There are more than 90 million smokers in the United States who represent a significant population at elevated risk for lung malignancy. In other epithelial tumors, it has been shown that if neoplastic lesions can be detected and treated at their intraepithelial stage, patient prognosis is significantly improved. Thus, new strategies to detect and treat lung preinvasive lesions are urgently needed in order to decrease the overwhelming public health burden of lung cancer. Limiting these advances is a poor knowledge of the earliest events that underlie lung cancer development and that would constitute markers and targets for early detection and prevention. This review summarizes the state of knowledge of human lung cancer pathogenesis and the molecular pathology of premalignant lung lesions, with a focus on the molecular premalignant field that associates with lung cancer development. Lastly, we highlight new approaches and models to study genome-wide alterations in human lung premalignancy in order to facilitate the discovery of new markers for early detection and prevention of this fatal disease. Cancer Prev Res; 9(7); 518–27. ©2016 AACR.Keywords
Funding Information
- Departments of Defense (W81XWH-10-1-1007)
- Departments of Defense (W81XWH-11-2-0161)
- NIH (R01HG005859)
- Cancer Prevention and Research Institute of Texas (RP150079)
This publication has 128 references indexed in Scilit:
- Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraBMC Medicine, 2013
- Sensitive and specific detection of mosaic chromosomal abnormalities using the Parent-of-Origin-based Detection (POD) methodBMC Genomics, 2013
- Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical TrialsCancers, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- The Life History of 21 Breast CancersCell, 2012
- Do all lung adenocarcinomas follow a stepwise progression?Lung Cancer, 2011
- Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancerBritish Journal of Cancer, 2011
- Tracing the tumor lineageMolecular Oncology, 2010
- SNP Arrays in Heterogeneous Tissue: Highly Accurate Collection of Both Germline and Somatic Genetic Information from Unpaired Single Tumor SamplesThe American Journal of Human Genetics, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007